Stay updated on Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page.

Latest updates to the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page
- Check2 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe 403 error content and its navigation elements were removed, and the page now presents the standard study details.SummaryDifference0.5%

- Check23 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the prior study content with an access-denied message. The presence of a 403 header and related HTML indicates the resource is blocked or unavailable to the public.SummaryDifference18%

- Check44 days agoChange DetectedA new revision label v3.6.6 was added to the page’s revision history, replacing the previous v3.6.5, indicating an internal update to the page.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page now displays a new revision tag, v3.6.5, replacing the previous v3.6.4, indicating a small maintenance update to the page’s template or content. This update does not appear to modify the study details or user-facing information on the page.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, signaling a newer revision of the page. This update reflects a metadata change rather than a substantive modification to the study details, eligibility criteria, or results.SummaryDifference0.0%

Stay in the know with updates to Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page.